KLRK1 and ovarian neoplasm: NKG2D CAR-T cells were able to lead to long-term, tumor-free survival in mice bearing established ovarian tumors. Tumor-free mice were able to reject a rechallenge with ovarian tumor cells 225 days after original tumor injection